PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35005470-0	2022	First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations.	Platinum	25-33	BRCA2 DNA repair associated	Homo sapiens	93-98	
35005470-2	2022	Case presentation: We report the case of a Japanese patient with advanced castration-resistant prostate cancer who exhibited a prominent response to platinum therapy and had coexisting BRCA2 and PTEN mutations according to retrospective multigene panel analysis.	Platinum	149-157	BRCA2 DNA repair associated	Homo sapiens	185-190